Venture Capital firm, QVentures, announces their latest pre-seed fund investment into Presentient Technologies, a software platform developing innovative tools for companies running clinical trials. The funding round was led by QVentures with participation from Episode1 and industry angels. Clinical trials [...]The post QVentures invests in Presentient Technologies, a SaaS platform developing tools for clinical trials appeared first on UK Business Angels Association.
Presentient is an England-based SaaS platform that provides solutions such as clinical trial prediction and analytics for pharmaceutical and drug development companies.